Fort Pitt Capital Group’s Sanofi SNY Stock Holding History

Fort Pitt Capital Group’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-200	Closed	-$10K	–	305
2020 Q4	$10K	Buy	+200	New	+$9.86K	﹤0.01%	285

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Fort Pitt Capital Group's SNY Position: Q1 2021 in Review

Fort Pitt Capital Group sold out of Sanofi (SNY) in Q1 2021, closing a stake of 200 shares — an estimated $10K sold.

Fort Pitt Capital Group first reported a position in SNY in Q4 2020 and held it in 1 quarter. The position peaked at $10K in Q4 2020. 573 funds tracked by Wall St. Rank hold SNY as of Q1 2021.

Fort Pitt Capital Group reported no remaining Sanofi position as of Q1 2021 after selling out during the quarter.
Fort Pitt Capital Group sold 200 Sanofi shares in Q1 2021, an estimated $10K.
Fort Pitt Capital Group first reported a position in Sanofi in Q4 2020 and held it in 1 quarter.
Fort Pitt Capital Group's Sanofi position peaked at $10K in Q4 2020.
573 funds tracked by Wall St. Rank held Sanofi as of Q1 2021.

Based on Fort Pitt Capital Group's 13F filing for Q1 2021, filed 16 Apr 2021.